Icon (ICLR) Depreciation & Amortization - Total (2017 - 2021)
Icon's (ICLR) quarterly Depreciation & Amortization - Total came in at $13.2 million in Q2 2021, up 17.7% year-over-year from $11.2 million in Q2 2020, and up 3.9% quarter-over-quarter from $12.7 million in Q1 2021.
Analysis
Icon (ICLR) Depreciation & Amortization - Total (2017 - 2021) Analysis & Trends
Icon (ICLR) has reported Depreciation & Amortization - Total for 5 consecutive years, with $13.2 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Depreciation & Amortization - Total rose 17.7% year-over-year to $13.2 million in Q2 2021; TTM through Jun 2021 was $50.2 million, a 10.72% increase from a year earlier, with the FY2025 full-year figure at $155.8 million, up 12.74% from the prior year.
- Depreciation & Amortization - Total was $13.2 million for Q2 2021 at Icon, up from $12.7 million in the prior quarter.
- Over five years, Depreciation & Amortization - Total peaked at $15.1 million in Q4 2018 and troughed at $10.0 million in Q1 2017.
- A 5-year average of $11.8 million and a median of $11.6 million in 2018 frame the typical range for Depreciation & Amortization - Total.
- Across the five-year window, Depreciation & Amortization - Total grew 29.47% in 2018 and retreated 25.12% in 2019, its largest moves.
- Over 5 years, Depreciation & Amortization - Total stood at $11.7 million in 2017, then grew by 29.47% to $15.1 million in 2018, then retreated by 25.12% to $11.3 million in 2019, then rose by 8.89% to $12.3 million in 2020, then climbed by 7.12% to $13.2 million in 2021.
- The last three Depreciation & Amortization - Total figures came in at $13.2 million (Q2 2021), $12.7 million (Q1 2021), and $12.3 million (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 6.56 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 13.22 Mn |
| Mar 31, 2021 | 12.72 Mn |
| Dec 31, 2020 | 12.34 Mn |
| Sep 30, 2020 | 11.91 Mn |
| Jun 30, 2020 | 11.23 Mn |
| Mar 31, 2020 | 11.41 Mn |
| Dec 31, 2019 | 11.33 Mn |
| Sep 30, 2019 | 11.36 Mn |
| Jun 30, 2019 | 11.33 Mn |
| Mar 31, 2019 | 11.58 Mn |
| Dec 31, 2018 | 15.13 Mn |
| Sep 30, 2018 | 11.65 Mn |
| Jun 30, 2018 | 11.93 Mn |
| Mar 31, 2018 | 11.85 Mn |
| Dec 31, 2017 | 11.69 Mn |
| Sep 30, 2017 | 11.36 Mn |
| Jun 30, 2017 | 10.37 Mn |
| Mar 31, 2017 | 10.02 Mn |